HYFT
ImmunoPrecise Antibodies Ltd.
1.50$
+4.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.3% | +20.6% | -11.7% | -25.7% | +34.7% | -34.6% | +3.2% | -78.0% | +3.1% | +10.5% | +14.5% | – | |
| – | +237.0% | -76.3% | -30.4% | -4.8% | -55.4% | -24.3% | +3.8% | +176.4% | +69.7% | +214.0% | -8.6% | – | |
| – | -130.3% | – | – | -158.9% | – | -156.7% | – | – | – | +2,845.8% | +103.1% | – | |
| – | -44.8% | +583.0% | -76.7% | -75.3% | +72.3% | +220.5% | -21.4% | -73.8% | -58.7% | -49.3% | +410.7% | – | |
| – | – | -2,049.1% | -76.3% | -75.3% | +72.3% | +220.5% | +65.5% | -87.5% | – | -98.9% | -152.7% | – | |
| – | – | – | – | – | – | – | – | +60.4% | – | – | – | – | |
| – | – | – | – | -52.2% | -115.0% | +175.3% | -25.7% | -68.7% | +1.0% | +151.0% | -30.1% | – | |
| – | – | +83.2% | +140.1% | -23.3% | +409.7% | -104.0% | -11.2% | – | -193.0% | -97.9% | – | – | |
| – | – | -1,583.2% | – | -183.3% | – | -123.6% | – | – | -116.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.